Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Basophil biomarkers as useful predictors for sublingual immunotherapy in allergic rhinitis.

Caruso M, Cibella F, Emma R, Campagna D, Tringali G, Amaradio MD, Polosa R.

Int Immunopharmacol. 2018 Jul;60:50-58. doi: 10.1016/j.intimp.2018.04.034. Epub 2018 Apr 25.

PMID:
29702283
2.

Flow cytometry for basophil activation markers: the measurement of CD203c up-regulation is as reliable as CD63 expression in the diagnosis of cat allergy.

Ocmant A, Peignois Y, Mulier S, Hanssens L, Michils A, Schandené L.

J Immunol Methods. 2007 Mar 30;320(1-2):40-8. Epub 2007 Jan 3.

PMID:
17275019
3.

Basophil expression of diamine oxidase: a novel biomarker of allergen immunotherapy response.

Shamji MH, Layhadi JA, Scadding GW, Cheung DK, Calderon MA, Turka LA, Phippard D, Durham SR.

J Allergy Clin Immunol. 2015 Apr;135(4):913-21.e9. doi: 10.1016/j.jaci.2014.09.049. Epub 2014 Nov 22.

PMID:
25457150
4.

Allergen-induced basophil CD203c expression as a biomarker for rush immunotherapy in patients with Japanese cedar pollinosis.

Nagao M, Hiraguchi Y, Hosoki K, Tokuda R, Usui T, Masuda S, Yamaguchi M, Fujisawa T.

Int Arch Allergy Immunol. 2008;146 Suppl 1:47-53. doi: 10.1159/000126061. Epub 2008 May 27.

PMID:
18504407
5.

Basophil allergen threshold sensitivity: a useful approach to anti-IgE treatment efficacy evaluation.

Nopp A, Johansson SG, Ankerst J, Bylin G, Cardell LO, Grönneberg R, Irander K, Palmqvist M, Oman H.

Allergy. 2006 Mar;61(3):298-302.

PMID:
16436137
6.

CD203c-based basophil activation test in allergy diagnosis: characteristics and differences to CD63 upregulation.

Sturm EM, Kranzelbinder B, Heinemann A, Groselj-Strele A, Aberer W, Sturm GJ.

Cytometry B Clin Cytom. 2010 Sep;78(5):308-18. doi: 10.1002/cyto.b.20526. Epub 2010 Apr 14.

7.

Effect on cell surface markers following allergen-induced desensitization of human whole-blood basophils.

Lund G, Jacobi H, Skov PS, Holm J, Lund K.

Int Arch Allergy Immunol. 2010;153(4):323-34. doi: 10.1159/000316343. Epub 2010 Jun 17.

PMID:
20558998
8.

Short-term preseasonal immunotherapy: is early clinical efficacy related to the basophil response?

Kepil Özdemir S, Sin BA, Güloğlu D, İkincioğulları A, Gençtürk Z, Mısırlıgil Z.

Int Arch Allergy Immunol. 2014;164(3):237-45. doi: 10.1159/000365628. Epub 2014 Aug 21.

PMID:
25170594
9.

Basophil CD203c levels are increased at baseline and can be used to monitor omalizumab treatment in subjects with nut allergy.

Gernez Y, Tirouvanziam R, Yu G, Ghosn EE, Reshamwala N, Nguyen T, Tsai M, Galli SJ, Herzenberg LA, Herzenberg LA, Nadeau KC.

Int Arch Allergy Immunol. 2011;154(4):318-27. doi: 10.1159/000321824. Epub 2010 Oct 25.

10.

Marked improvement of the basophil activation test by detecting CD203c instead of CD63.

Boumiza R, Monneret G, Forissier MF, Savoye J, Gutowski MC, Powell WS, Bienvenu J.

Clin Exp Allergy. 2003 Feb;33(2):259-65.

PMID:
12580920
11.
12.

Recombinant allergens promote expression of CD203c on basophils in sensitized individuals.

Hauswirth AW, Natter S, Ghannadan M, Majlesi Y, Schernthaner GH, Sperr WR, Bühring HJ, Valenta R, Valent P.

J Allergy Clin Immunol. 2002 Jul;110(1):102-9.

PMID:
12110828
13.

Reliability of basophil activation test using CD203c expression in diagnosis of pollen allergy.

Özdemir SK, Güloğlu D, Sin BA, Elhan AH, Ikincioğulları A, Mısırlıgil Z.

Am J Rhinol Allergy. 2011 Nov-Dec;25(6):e225-31. doi: 10.2500/ajra.2011.25.3723.

PMID:
22185730
14.

Basophil Activation Test is a Relevant Biomarker of the Outcome of Rapid Desensitization in Platinum Compounds-Allergy.

Giavina-Bianchi P, Galvão VR, Picard M, Caiado J, Castells MC.

J Allergy Clin Immunol Pract. 2017 May - Jun;5(3):728-736. doi: 10.1016/j.jaip.2016.11.006. Epub 2016 Dec 27.

PMID:
28034549
15.

CD203c expression on human basophils is associated with asthma exacerbation.

Ono E, Taniguchi M, Higashi N, Mita H, Kajiwara K, Yamaguchi H, Tatsuno S, Fukutomi Y, Tanimoto H, Sekiya K, Oshikata C, Tsuburai T, Tsurikisawa N, Otomo M, Maeda Y, Hasegawa M, Miyazaki E, Kumamoto T, Akiyama K.

J Allergy Clin Immunol. 2010 Feb;125(2):483-489.e3. doi: 10.1016/j.jaci.2009.10.074.

PMID:
20159259
16.

Single-allergen sublingual immunotherapy versus multi-allergen subcutaneous immunotherapy for children with allergic rhinitis.

Wang ZX, Shi H.

J Huazhong Univ Sci Technolog Med Sci. 2017 Jun;37(3):407-411. doi: 10.1007/s11596-017-1748-2. Epub 2017 Jun 6.

PMID:
28585143
17.

Changes in basophil activation during grass-pollen sublingual immunotherapy do not correlate with clinical efficacy.

Van Overtvelt L, Baron-Bodo V, Horiot S, Moussu H, Ricarte C, Horak F, Zieglmayer P, Zieglmayer R, Montagut A, Galvain S, de Beaumont O, Le Gall M, Moingeon P.

Allergy. 2011 Dec;66(12):1530-7. doi: 10.1111/j.1398-9995.2011.02696.x. Epub 2011 Aug 29.

PMID:
21883279
18.

Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children.

Thyagarajan A, Jones SM, Calatroni A, Pons L, Kulis M, Woo CS, Kamalakannan M, Vickery BP, Scurlock AM, Wesley Burks A, Shreffler WG.

Clin Exp Allergy. 2012 Aug;42(8):1197-205. doi: 10.1111/j.1365-2222.2012.04028.x.

19.

CD-sens: a biological measure of immunological changes stimulated by ASIT.

Nopp A, Cardell LO, Johansson SG, Oman H.

Allergy. 2009 May;64(5):811-4. doi: 10.1111/j.1398-9995.2008.01900.x. Epub 2009 Feb 13.

PMID:
19220221
20.

Distinct parameters of the basophil activation test reflect the severity and threshold of allergic reactions to peanut.

Santos AF, Du Toit G, Douiri A, Radulovic S, Stephens A, Turcanu V, Lack G.

J Allergy Clin Immunol. 2015 Jan;135(1):179-86. doi: 10.1016/j.jaci.2014.09.001.

Supplemental Content

Support Center